Rankings
▼
Calendar
FATE FY 2025 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FATE
Fate Therapeutics, Inc.
$158M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
-51.2% YoY
Gross Profit
-$6M
-94.1% margin
Operating Income
-$148M
-2222.4% margin
Net Income
-$136M
-2051.1% margin
EPS (Diluted)
$-1.15
Cash Flow
Operating Cash Flow
-$106M
Free Cash Flow
-$112M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$319M
Total Liabilities
$112M
Stockholders' Equity
$207M
Cash & Equivalents
$47M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$14M
-51.2%
Gross Profit
-$6M
$14M
-145.9%
Operating Income
-$148M
-$210M
+29.8%
Net Income
-$136M
-$186M
+26.8%
← Q4 2024
All Quarters
Q1 2025 →